Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/the-new-england-journal-of-medicine/anticytokine-therapy-in-rheumatoid-arthritis-0rFcHQmBKp
References (14)
-
J. Álvaro-Gracia, Nathan, J., Zvaifler, G. Firestein (1990)
Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.The Journal of clinical investigation, 86 6
-
Pierre Miossec, M. Elhamiani, Xavier Edmonds‐Alt, Jacques Sany, Michel Hirn (1990)
Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.Arthritis and rheumatism, 33 11
-
G. Firestein, N. Zvaifler (1990)
How important are T cells in chronic rheumatoid synovitis?Arthritis and rheumatism, 33 6
-
P. Lent, F. Loo, A. Holthuysen, L. Bersselaar, H. Vermeer, W. Berg (1995)
Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.The Journal of rheumatology, 22 12
-
M. Elliott, R. Maini, M. Feldmann, J. Kalden, C. Antoni, J. Smolen, B. Leeb, F. Breedveld, J. Macfarlane, J. Bijl, J. Woody (1994)
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 344
-
M. Weinblatt, Herbert Kaplan, Bernard Germain, Sidney Block, S. Solomon, R. Merriman, Frederick Wolfe, B. Wall, L. Anderson, Eric Gall, Dennis Torretti, Barbara Weissman (1994)
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.Arthritis and rheumatism, 37 10
-
G. Firestein (1996)
Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?Arthritis and rheumatism, 39 11
-
P. Tak, P. Taylor, F. Breedveld, T. Smeets, M. Daha, P. Kluin, A. Meinders, R. Maini (1996)
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.Arthritis and rheumatism, 39 7
-
U. Muller-Ladner, J. Kriegsmann, Barry Franklin, S. Matsumoto, T. Geiler, E. Renate, Gay, S. Gay (1996)
Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.The American journal of pathology, 149 5
-
Fibroblasts Bv, J. Dayer, B. Beutler, Argo Cerami
Brief Definitive Report Cachectin/tumor Necrosis Factor Stimulates Collagenase and Prostaglandin E2 Production by Human Synovial Cells and Dermal -
L. Moreland, Scott Baumgartner, M. Schiff, E. Tindall, R. Fleischmann, A. Weaver, R. Ettlinger, S. Cohen, W. Koopman, K. Mohler, M. Widmer, C. Blosch (1997)
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.The New England journal of medicine, 337 3
-
Richard Williams, L. Mason, M. Feldmann, R. Maini (1994)
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.Proceedings of the National Academy of Sciences of the United States of America, 91 7
-
William Koopman (1993)
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?Annals of the Rheumatic Diseases, 52
-
J. Keffer, L. Probert, Haris Caziaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, G. Kollias (1991)
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.The EMBO Journal, 10
- Publisher
- The New England Journal of Medicine
- Copyright
- Copyright © 1997 Massachusetts Medical Society. All rights reserved.
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- DOI
- 10.1056/NEJM199707173370310
- pmid
- 9219708
- Publisher site
- See Article on Publisher Site
Abstract
Only a few years ago, little was known about the role of cytokines in rheumatoid arthritis. The original view of the cytokine milieu in the inflamed joint as a melange of factors from various cells was clarified by two observations.1 First, in inflammation of rheumatoid arthritis, cytokines from macrophages and fibroblasts dominate, and second, the cytokine profile within the macrophage and fibroblast reflects a hierarchy, with interleukin-1 and tumor necrosis factor α (TNF-α) assuming particular importance. Anticytokine therapy for rheumatoid arthritis has now reached the clinic, and the report in this issue of the Journal by Moreland et al.2 adds . . .
Journal
The New England Journal of Medicine – The New England Journal of Medicine
Published: Jul 17, 1997